Related Experiment Video
Updated: Jul 20, 2026

An Intravital Microscopy-Based Approach to Assess Intestinal Permeability and Epithelial Cell Shedding Performance
Published on: December 3, 2020
Abnormal intestinal permeability in primary biliary cirrhosis.
Jordan J Feld1, Jonathan Meddings, E Jenny Heathcote
1Division of Gastroenterology, University of Toronto, Toronto, Ontario, Canada. feldj@niddk.nih.gov
Patients with primary biliary cirrhosis (PBC) exhibit increased gastrointestinal permeability, suggesting a potential link between gut health and AMA development. This finding may offer new insights into PBC pathogenesis and treatment strategies.
Area of Science:
- Gastroenterology
- Immunology
- Hepatology
Background:
- Antimitochondrial antibodies (AMAs) in primary biliary cirrhosis (PBC) may arise from molecular mimicry with gut bacteria.
- Increased gastrointestinal permeability could facilitate immune system exposure to gut flora.
Purpose of the Study:
- To compare gastrointestinal permeability in PBC patients versus hepatitis C patients and healthy controls.
- To investigate the role of gut permeability in the development of AMAs in PBC.
Main Methods:
- Subjects ingested a mixture of sucrose, lactulose, and mannitol.
- Eight-hour urinary sugar excretion was measured to assess gastric, proximal small intestinal, and small bowel permeability.
- Antiendomysial antibody testing excluded subclinical celiac disease.
Main Results:
- PBC patients showed significantly higher sucrose excretion, indicating abnormal gastric or proximal small intestinal permeability.
- Elevated lactulose:mannitol ratio in PBC patients suggested increased small bowel permeability compared to controls.
- Hepatitis C patients did not exhibit increased sucrose excretion but had similar lactulose:mannitol ratios to PBC patients.
Conclusions:
- Primary biliary cirrhosis is associated with increased permeability in both the stomach and small bowel.
- The exact relationship between increased gut permeability and PBC (cause, consequence, or manifestation) remains undetermined.
Related Concept Videos
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease III: Crohn's Disease
Chronic Pancreatitis II: Pathophysiology
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
